Abstract
Breast neuroendocrine tumors (NETs) are a rare form of breast cancer. Some studies, with a limited number of sequenced genes and involved patients, have reported of different mutation rates in breast NET compared to IDC. The aim of this study was to investigate the comprehensive genetic landscape of breast NETs and compare it to those of IDCs and pancreatic NETs.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
